Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study
- PMID: 37333608
- PMCID: PMC10273400
- DOI: 10.3389/fpsyg.2023.1078992
Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study
Abstract
Background: The COVID-19 outbreak had a negative psychological impact on cancer patients. In this study, we analyzed emotional distress and quality of life in patients diagnosed with sarcoma during the first year of the pandemic compared to the previous year.
Methods: We retrospectively enrolled patients with soft tissue, bone sarcoma, and aggressive benign musculoskeletal diseases diagnosed during the pandemic (COVID group) or the year before (control group) at the IRCCS Regina Elena National Cancer Institute in Rome. Patients who had undergone a psychological assessment with the EORTC QLQ-C30 and the Distress Thermometer at diagnosis were included in the final analysis. We analyzed whether there is a difference in the various domains of quality of life between the two groups and whether there are changes over time in each group.
Results: We enrolled 114 patients (72 control group; 42 COVID group), affected by soft tissue (64%), bone sarcoma (29%), and aggressive benign musculoskeletal diseases (7%). We did not observe significant differences in the health-related quality of life domains in the control and COVID groups, except for the financial domain (p = 0.039), with 9.7% vs. 23.8% of patients with a score > 0 in the control and COVID groups, respectively. We observed emotional distress at diagnosis in 48.6% of patients in the control group vs. 69.0% in the COVID group (p = 0.034). In the control group, we observed an improvement in physical function (p = 0.043) and in QoL (p = 0.022), while in the COVID group, we observed a deterioration in role function (p = 0.044) during follow-up. In the COVID group, 22.2% of patients were concerned about COVID-19, 61.1% by tumor, 91.1% stated that the pandemic worsened their subjective perception of cancer, and 19.4% perceived that their quality of care had worsened.
Conclusion: We observed a higher level of distress among patients diagnosed during the pandemic compared to the year before, probably due to the increased concern for both infection and cancer, the worsened perception of health status, and the perception of a poorer quality of health care.
Keywords: COVID-19; aggressive benign musculoskeletal disease; bone sarcoma; quality of life; sarcoma; soft tissue sarcoma.
Copyright © 2023 Onesti, Vari, Minghelli, Nardozza, Rossi, Sperati, Checcucci, Faltyn, Cercato, Cosimati, Salvatori, Biagini, Ciliberto, Ferraresi and Maggi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study).Front Oncol. 2022 Sep 20;12:1000056. doi: 10.3389/fonc.2022.1000056. eCollection 2022. Front Oncol. 2022. PMID: 36249051 Free PMC article.
-
Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic.Int J Environ Res Public Health. 2022 Mar 21;19(6):3731. doi: 10.3390/ijerph19063731. Int J Environ Res Public Health. 2022. PMID: 35329416 Free PMC article.
-
Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.PLoS One. 2019 Sep 26;14(9):e0210731. doi: 10.1371/journal.pone.0210731. eCollection 2019. PLoS One. 2019. PMID: 31557183 Free PMC article.
-
The effects of the COVID-19 pandemic on psychological stress in breast cancer patients.BMC Cancer. 2021 Dec 31;21(1):1356. doi: 10.1186/s12885-021-09012-y. BMC Cancer. 2021. PMID: 34972520 Free PMC article.
-
Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.BMC Cancer. 2021 Jan 27;21(1):99. doi: 10.1186/s12885-021-07793-w. BMC Cancer. 2021. PMID: 33499819 Free PMC article.
References
-
- Bargon C. A., Batenburg M. C. T., van Stam L. E., Mink van der Molen D. R., van Dam I. E., van der Leij F., et al. . (2021). Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors. JNCI Cancer Spectr. 5:104. doi: 10.1093/jncics/pkaa104, PMID: - DOI - PMC - PubMed
-
- Bethea T. N., Zhai W., Zhou X., Ahles T. A., Ahn J., Cohen H. J., et al. . (2022). Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study. Cancer Med. 11, 3352–3363. doi: 10.1002/cam4.4682, PMID: - DOI - PMC - PubMed
-
- Distress Thermometer Tool Translations . (n.d.). Available at: https://www.nccn.org/global/what-we-do/distress-thermometer-tool-transla...
LinkOut - more resources
Full Text Sources